Western blot analysis using specific antibodies against Akt, Akt1, Akt2, GSK-3β, and GS, phosphorylated (p-)Akt (Ser473), -Akt1 (Ser473), -Akt2 (Ser474), –GSK-3β, and -GS, hexokinase II (HK II; Cell Signaling Technology, Danvers, MA), TRB3 (EMD Millipore, Billerica, MA), connective tissue growth factor (CTGF), transforming growth factor-β1 (TGF-β1), plasminogen activator inhibitor-1 (PAI-1), tumor necrosis factor-α (TNF-α), peroxisome proliferator–activated receptor γ coactivator-1α (PGC-1α), GAPDH, β-actin (Santa Cruz Biotechnology, Santa Cruz, CA), and MT (DakoCytomation, Santa Clara, CA) was performed as described previously (14–16,18,19).
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.